Neuroimaging in Atypical AD: Considerations for Clinical Trials

Abstract

Neuroimaging can assess different pathophysiological features of the brain in Alzheimer's disease (AD), including structure, function and protein deposition, and can be used to help identify patients for clinical treatment trials and monitor and assess potential treatment effects on disease progression.

The paper